Investors

Discover Virbac's Statement on extra-financial performance

SALES 2020
934 M
59%
Companion
animals
41%
Food
producing
animals

(in € million)

Financial public release
& News

Aquaculture : Virbac completes the acquisition of Centrovet

2021/11/05 - Financial public releases

vignette-corpo-centrovet.pngVirbac announces the acquisition of the remaining minority shares of the Centrovet group.

Read more

2021 third quarter consolidated sales

2021/10/18 - Financial public releases

Excellent revenue growth of 21.2% at the end of September at comparable exchange rates and scope (+16.4% at constant rates and real scope), driven by a very solid third-quarter performance again in all areas

Read more

Virbac and Jectas Innovators sign an agreement

2021/09/29 - Financial public releases

partenariat-jectas-vignette-corpo.pngVirbac and Jectas Innovators are proud to announce the signature of a collaborative agreement for the development of animal health vaccine(s).

Read more

Events
Monday March 21

2021 results

From 2022/03/21 To 

Read moreRead less

Monday March 21, 2022 after market close

2021 results
(quiet period from February 21, 2022)​

Tuesday March 22

SFAF meeting - 2021 financial & strategic information

From 2022/03/22 To 

Read moreRead less

Tuesday March 22, 2022
SFAF meeting - 2021 financial & strategic information
Thursday April 14

2022 first quarter sales

From 2022/04/14 To 

Read moreRead less

Thursday April 14, 2022 after market close

2022 first quarter sales
(quiet period from March 31, 2022)

Past Events
Tuesday January 19

2021 fourth quarter year sales

From 2021/01/19 To 

Read moreRead less

Tuesday January 19, 2022 after market close

2021 fourth quarter year sales 
(quiet period from January 5, 2022)